Social media is an increasingly important part of the job description for med comms professionals, as more and more pharma companies look to take advantage of the opportunity to engage and influence large numbers of people at a relatively low cost. While regulation and compliance rules can make social media marketing more challenging, it’s not hard to make an impact when you follow our eight great tips for social success:
Our understanding of DNA and genetics has come a long way in the past century. What started as small scientific breakthroughs paved the way for greater discoveries, and led us to today where the study of genomics is transforming medical care, developing technology that could cure a patient of disease even before they are born. In our first of two articles on DNA, we look at the story so far and ask the question, where do we go from here?
Choosing the right recruitment agency could be the difference between getting your dream job and never even knowing it was out there. To find your perfect match, we’ve put together our top 10 tips to help you sort the best from the rest:
After months of complex negotiations, news finally broke in January of Johnson & Johnson’s multi-billion pound deal with Swiss biotech Actelion in what has become the biggest European pharma deal in 13 years. While mergers and acquisitions can be unsettling for those involved, they can also be a springboard for your career. Here’s our top tips for surviving, and thriving, when your working environment changes:
Getting noticed in a competitive jobs market can be difficult, particularly if you are relying on your CV and a cover letter to get you a foot in the door for an interview. Maybe 2017 should be the year you ditch the traditional CV and take a chance on something more creative to help you stand out from the crowd.
It has been a vintage year for Paramount Recruitment, with a change in the agency’s focus, some major client wins and the launch of a refreshed brand image to reflect the company’s new vision. Here, Director Eugene McDaid shares his thoughts on 2016 and the challenges that lay ahead in 2017.
A recent survey carried out by the Equal Opportunities Commission found that a failed or wrong recruitment left small businesses anywhere between £1,000 and £28,000 out of pocket. With so much at stake financially, can you really afford to get your recruitment strategy wrong?
The concept of precision medicine – treatment tailored to a patient’s individual genetic make-up – is fast becoming a reality thanks to advances in genomic research and the introduction of electronic medical records. But before science fiction becomes science fact, we need to overcome the inherent issues surrounding the use of confidential medical records.
Big Data is big business, and not just for the Google, Apple and Facebook's of this world. The pharma industry produces large amounts of data, and with the rapid growth of digital health technology, this is only going to increase in the future. So, for talented individuals with data skills, the life sciences could be your next calling.
Brexit will undoubtedly be a major turning point for Britain and a time of great uncertainty – no more so than for pharma companies, as they await the fate of the regulations which have governed the UK industry and its products for so long.
If you are thinking about your next career move, chances are you’re already looking at opportunities at the kind of well-known pharma and life science companies which are going to look great on your CV. But what if your next big move was to a start-up? Here, we’ve put together our top 5 reasons why joining a small company can get the best out of you.
How far would you go to help science find a cure for a disease that kills hundreds or even millions of people every year? Most of us are happy to donate money to medical research charities – but what if you were asked to donate your genome, the unique map of your genes and DNA, to scientific research? As the field of genomics continues to grow, this may be a question we are all asked to consider in the not too distant future.
Digital technology has transformed the way we communicate with each other, putting the ability to call, message and share thoughts at our fingertips 24/7. For medical communications agencies, the global success of digital technology has heralded a major shift away from tried and tested traditional media and methods, and a leap towards constantly evolving online platforms, where only those that adapt and innovate will survive.
Step 1: Diagnosis, Step 2: Treatment – the two cornerstones of clinical practice follow each other naturally, sharing considerations to plan a course of action. But what of initial prevention? What of Step Zero? In their revitalisation of personalised care, supporters of genomic medicine may also change how we utilise preventative measures, and the pharmaceuticals that bring them.
Modern science, perhaps more than any other sphere, benefits from open, interconnected networks of knowledge and of people. We continue to pool larger subject samples, to share more data, and to seek the expertise of specialists across a veritable pick 'n' mix of labs.